INTRODUCTION: We have previously shown that a tag single nucleotide polymorphism (rs10235235), which maps to the CYP3A locus (7q22.1), was associated with a reduction in premenopausal urinary estrone glucuronide levels and a modest reduction in risk of breast cancer in women age <=50 years.="" methods:="" we="" further="" investigated="" the="" association="" of="" rs10235235="" with="" breast="" cancer="" risk="" in="" a="" large="" case="" control="" study="" of="" 47,346="" cases="" and="" 47,570="" controls="" from="" 52="" studies="" participating="" in="" the="" breast="" cancer="" association="" consortium.="" genotyping="" of="" rs10235235="" was="" conducted="" using="" a="" custom="" illumina="" infinium="" array.="" stratified="" analyses="" were="" conducted="" to="" determine="" whether="" this="" association="" was="" modified="" by="" age="" at="" diagnosis,="" ethnicity,="" age="" at="" menarche="" or="" tumor="" characteristics.="" results:="" we="" confirmed="" the="" association="" of="" rs10235235="" with="" breast="" cancer="" risk="" for="" women="" of="" european="" ancestry="" but="" found="" no="" evidence="" that="" this="" association="" differed="" with="" age="" at="" diagnosis.="" heterozygote="" and="" homozygote="" odds="" ratios="" (ors)="" were="" or="0.98" (95%="" ci="" 0.94,="" 1.01;="" p="0.2)" and="" or="0.80" (95%="" ci="" 0.69,="" 0.93;="" p="0.004)," respectively="" (ptrend="0.02)." there="" was="" no="" evidence="" of="" effect="" modification="" by="" tumor="" characteristics.="" rs10235235="" was,="" however,="" associated="" with="" age="" at="" menarche="" in="" controls="" (ptrend="0.005)" but="" not="" cases="" (ptrend="0.97)." consequently="" the="" association="" between="" rs10235235="" and="" breast="" cancer="" risk="" differed="" according="" to="" age="" at="" menarche="" (phet="0.02);" the="" rare="" allele="" of="" rs10235235="" was="" associated="" with="" a="" reduction="" in="" breast="" cancer="" risk="" for="" women="" who="" had="" their="" menarche="" age="">=15 years (ORhet = 0.84, 95% CI 0.75, 0.94; ORhom = 0.81, 95% CI 0.51, 1.30; Ptrend = 0.002) but not for those who had their menarche age <=11 years="" (orhet="1.06," 95%="" ci="" 0.95,="" 1.19,="" orhom="1.07," 95%="" ci="" 0.67,="" 1.72;="" ptrend="0.29)." conclusions:="" to="" our="" knowledge="" rs10235235="" is="" the="" first="" single="" nucleotide="" polymorphism="" to="" be="" associated="" with="" both="" breast="" cancer="" risk="" and="" age="" at="" menarche="" consistent="" with="" the="" well-documented="" association="" between="" later="" age="" at="" menarche="" and="" a="" reduction="" in="" breast="" cancer="" risk.="" these="" associations="" are="" likely="" mediated="" via="" an="" effect="" on="" circulating="" hormone="" levels.="">=11>=50>